A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Clinical trial NCT06508021 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06508021
- Sponsor
- Ashibio Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-25
- Primary completion
- 2029-02-04
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.